MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CRVS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Corvus Pharmaceuticals (CRVS) Ownership - Who owns Corvus Pharmaceuticals?

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
901 Gateway Boulevard, Third Floor
Phone
+1 650 900-4520
Employees
37
Web
https://www.corvuspharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.22B
P/E Ratio
N/A
Total Cash
236.71M
Projected Growth
N/A
Total Debt
834K
Revenue
N/A
Risk (Beta)
2.15
Dividend Yield
N/A
Total Cash/Share
2.81
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CRVS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for CRVS
A.I. Advisor
published General Information

General Information

a provider of anticancer immuno-oncology drugs

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Major
Address
901 Gateway Boulevard, Third Floor
Phone
+1 650 900-4520
Employees
37
Web
https://www.corvuspharma.com